omniture

China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2011 Financial Results

2011-06-03 17:27 1664

Earnings Call Scheduled for 8:00 a.m. ET on June 13, 2011

HONG KONG, June 3, 2011 /PRNewswire-Asia/ -- China Cord Blood Corporation (NYSE: CO) ("the Company") today announced its plan to release financial results for the fourth quarter and full year of fiscal year 2011 on Friday, June 10, 2011, after market close in the US.  

The Company will hold a conference call at 8:00 a.m. ET on Monday, June 13, 2011 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and answer session.  Interested parties may access the audio webcast through the Company's IR website at http://ir.chinacordbloodcorp.com. A replay of the webcast will be accessible two hours after the presentation and available for three weeks at the same URL link above.  Listeners may also access the call by dialing 1-718-354-1231 or 1-866-519-4004 for US callers or +852-2475-0994 for Hong Kong callers, access code: 65722327.  

Please dial in ten minutes prior to the conference call to ensure proper connection, and be prepared to provide your name and company to the operator.

Supplemental financial information referenced in the conference call and the fourth quarter and full year fiscal 2011 earnings press release will be available at http://www.chinacordbloodcorp.com, in the section titled Investor Center/Press Release, after 4:00 p.m. ET on Friday, June 10, 2011.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses.  Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services.  For more information, please visit the Company's website at http://www.chinacordbloodcorp.com.

For more information, please contact:

China Cord Blood Corporation
Ms. Joeling Law
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com 

ICR, LLC
In New York: Ashley De Simone: 1-646-277-1227
In Beijing: Wen Lei Zheng: +86-10-6583-7510

Source: China Cord Blood Corporation
Related Stocks:
NYSE:CO
collection